| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |